Form 4: Abbott Laboratories Executive Vice President Mary K. Moreland Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President Mary K. Moreland reports the disposition and acquisition of Abbott Laboratories common shares, including shares withheld for tax obligations and shares sold on the open market.
Summary
- On February 29, 2024, Mary K. Moreland, an Executive Vice President at Abbott Laboratories, had 5,862 common shares withheld to cover tax obligations at a price of $120.05.
- On March 1, 2024, Moreland sold 676 common shares at a price of $118.50.
- Following these transactions, Moreland directly owns 91,260 common shares and indirectly owns 11,399 shares through a Profit Sharing Trust as of March 1, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect insider trading activity, which is closely monitored for compliance and potential insights into company performance.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | 5,862 common shares withheld for tax obligations at $120.05 per share. |
| 03/01/2024 | 676 common shares sold at $118.50 per share; balance in the Abbott Laboratories Stock Retirement Trust as of this date. |
| 03/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.